Richard Newcomb Stillwell
Director · Tonix Pharmaceuticals Holding Corp.
- 2026
- Jun 9, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Richard Newcomb Stillwell files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Seth Lederman - $373K in TNXP purchases and sales in the last 12 months
- Carolyn E. Taylor - $15K in TNXP purchases and sales in the last 12 months
- Richard H. Bagger - $13K in TNXP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Richard Newcomb Stillwell?
Richard Newcomb Stillwell is a corporate insider, tracked as Director of Tonix Pharmaceuticals Holding Corp. (TNXP). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Richard Newcomb Stillwell last file a Form 4?
The most recent primary Form 4 on record is dated 9 June 2026, one of 2 filings going back to 2026.
Has Richard Newcomb Stillwell been buying or selling stock?
Recorded transactions: 1 open-market purchase ($58K) and 0 open-market sales across all tracked filings.
